• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?
RESEARCH UPDATE

SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?

October 1, 2022
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Dr. Feder, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

REVIEW OF: Mahr F et al, J Child Adolesc Psychopharmacol 2022;32(2): 117–121 

STUDY TYPE: Retrospective chart review 

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID. 

Researchers reviewed the charts of 53 children and teens with ARFID treated in a partial hospital program. These charts were selected because the patients were given either SSRIs only or SSRIs with hydroxyzine as part of their treatment. The group was largely pubertal females with body mass index (BMI) of 15–16. To track progress with weight gain, this study followed the percent median body mass index, or %MBMI: the patient’s BMI divided by the median BMI for their age, then multiplied by 100. A typical goal is for patients to achieve a %MBMI of 90 to consider the treatment clinically meaningful. 

All patients had significant anxiety. Those who took hydroxyzine in addition to SSRIs were older than those who did not (13 vs 11), were made up of fewer female patients (64% vs 92%), and had more depressive symptoms on the Child Depression Inventory (62 vs 53). All patients benefited from SSRIs, with reduced anxiety, depression, and fear of eating. Patients in both categories improved weight gain, with those on SSRIs alone experiencing a %MBMI increase from 88 to 96 over the course of a year, and those who received SSRIs + hydroxyzine up from 89 to 98 over the same period. Hydroxyzine also helped subjective fear of eating as well as nausea in the more severe cohort of patients who received both medications. Side effects included mild sedation and fatigue for hydroxyzine and headache for SSRIs. 

The authors suggest starting SSRIs at 5 mg of fluoxetine (or equivalent) and titrating slowly to prevent paradoxically increasing anxiety. Hydroxyzine takes 15–30 minutes to act and peaks around two hours. The authors recommend dosing 0.5 mg/kg every four to six hours as needed for anxiety. Hydroxyzine liquid is helpful for patients who have trouble swallowing pills. 

Carlat Take
While this was a small uncontrolled study of patients in a relatively high level of care, it reminds us to assess for anxiety in ARFID. Of course, we need more research, but in the meantime SSRIs may help anxiety in ARFID, and adding hydroxyzine to an SSRI may help in severe cases of ARFID with comorbid symptoms.

Child Psychiatry Research Update
KEYWORDS ARFID child psychiatry eating disorders hydroxyzine research update ssris
    Eic photo joshua d feder md jpg 150x150
    Joshua Feder, MD

    Trisomy 21: An Overview for Child Psychiatrists

    More from this author
    www.thecarlatreport.com
    Issue Date: October 1, 2022
    SUBSCRIBE NOW
    Table Of Contents
    Note From the Editor-in-Chief
    Bipolar Spectrum Disorders in Children and Adolescents
    Assessing and Treating Catatonia in Children and Adolescents
    Assessing Sensory Processing Challenges
    Consider Catatonia in Your Differential
    SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?
    Pediatric Bipolar Depression: How Do We Rate a New Meta-Analysis?
    Ask the Editor: Is Silexan Safe for Children and Adolescents?
    CME Post-Test, Catatonia in Children and Adolescents, CCPR, Oct/Nov/Dec 2022
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2432683359.jpg
      Child Psychiatry

      Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

      The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. Stay with us as we talk about the...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.